171 results on '"Tomiyama, Takahiro"'
Search Results
2. What Are Risk Factors for Graft Loss in Patients Who Underwent Simultaneous Splenectomy During Living-donor Liver Transplantation?
3. Clinical Significance of Signal Regulatory Protein Alpha (SIRPα) Expression in Hepatocellular Carcinoma
4. Effect of Early Enteral Nutrition on Graft Loss After Living Donor Liver Transplantation: A Propensity Score Matching Analysis
5. A rare case of unresectable, microsatellite instability-high hepatocellular carcinoma and an examination of the tumor microenvironment
6. Predictive Factors for the Resectable Type of Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplant
7. ASO Visual Abstract: Clinical Significance of Signal Regulatory Protein Alpha (SIRPα) Expression in Hepatocellular Carcinoma
8. Caution for living donor liver transplantation with congenital portosystemic shunt: a case report
9. Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma
10. The Significant Prognostic Factors in Prolonged Intensive/High Care Unit Stay After Living Donor Liver Transplantation
11. Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes
12. 333.12: Up-Regulated LRRN2 Expression as a Marker for Graft Quality in Living Donor Liver
13. 333.5: Osteopenia Predicts Posttransplant Survival Among Livingdonor Liver Transplant Recipients
14. Impact of ACSL4 on the prognosis of hepatocellular carcinoma: Association with cancer‐associated fibroblasts and the tumour immune microenvironment
15. Acute death caused by invasive aspergillosis after living-donor liver transplantation despite good graft function: a case report
16. Outcome of living-donor liver transplantation for patients older than age 70 years, with respect to preserved performance status and graft quality
17. The development of a rapid, high-throughput neutralization assay using a SARS-CoV-2 reporter
18. A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients
19. Clinical association between intraoperative indocyanine green fluorescence imaging pattern, preoperative Gd‐EOB‐DTPA‐enhanced magnetic resonance imaging findings, and histological differentiation in hepatocellular carcinoma
20. Prediction Model with HLA-A*33:03 Reveals Number of Days to Develop Liver Cancer from Blood Test
21. Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study
22. Cancer‐associated fibroblasts promote tumor cell growth via miR ‐493‐5p in intrahepatic cholangiocarcinoma
23. Autoimmune Hepatitis in an Immunosuppression-Free Patient Who Underwent Living Donor Liver Transplantation From an Identical Twin: A Case Report
24. A rare case of unresectable, microsatellite instability-high hepatocellular carcinoma and an examination of the tumor microenvironment
25. Preoperative serum brain‐derived neurotrophic factor as a predictive biomarker for sepsis after living‐donor liver transplantation
26. Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature
27. Up‐regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation
28. Low syntaxin 17 expression in donor liver is associated with poor graft prognosis in recipients of living donor liver transplantation
29. Outcomes of living‐donor liver transplantation for acute‐on‐chronic liver failure based on newly proposed criteria in Japan
30. Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients
31. Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma.
32. Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma
33. Clinical effects of the use of the indocyanine green fluorescence imaging technique in laparoscopic partial liver resection
34. The ratio of serum des‐gamma‐carboxy prothrombin to tumor volume as a new biomarker for early recurrence of resected hepatocellular carcinoma
35. Myeloid‑derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
36. Preoperative serum brain‐derived neurotrophic factor as a predictive biomarker for sepsis after living‐donor liver transplantation.
37. Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status
38. ASO Author Reflections: Future Perspectives of Novel Prognostic Predictor of Vessels that Encapsulate Tumor Cluster (VETC) for Hepatocellular Carcinoma
39. DsRNA Sequencing for RNA Virus Surveillance Using Human Clinical Samples
40. Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma
41. DsRNA Sequencing for RNA Virus Surveillance Using Human Clinical Samples
42. Extensive portal thrombectomy with secure shunt ligation should be more strongly emphasized in the real-world setting
43. Construction of a genetic linkage map and detection of quantitative trait locus for the ergothioneine content in tamogitake mushroom (Pleurotus cornucopiae var. citrinopileatus)
44. ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma
45. Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status.
46. CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
47. Clinicopathologic Features of Patients With Primary Hepatocellular Carcinoma Surviving Without Recurrence More Than 10 Years After Primary Hepatic Resection
48. Living-Donor Liver Transplantation for Patients With Extrahepatic Malignancy: A Series of 14 Patients in a Single Institution
49. Prevention of bile duct injury using indocyanine green fluorescence in laparoscopic liver cyst fenestration for giant liver cyst: a case report.
50. ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.